Galapagos (GB:0JXZ) has released an update.
Galapagos NV, a biotech company specializing in medicines for unmet medical needs, has received a notification from FMR LLC indicating a decrease in their shareholding to 4.08%, falling below the 5% threshold. This change in FMR LLC’s stake, which accounts for a portion of Galapagos’ 65,897,071 outstanding shares, was detailed in a transparency notice on Galapagos’ website.
For further insights into GB:0JXZ stock, check out TipRanks’ Stock Analysis page.
